Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $9.0 million.

  • Chemours' Change in Accured Expenses fell 8636.36% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.0 million, marking a year-over-year increase of 10872.27%. This contributed to the annual value of -$660.0 million for FY2024, which is 20280.37% down from last year.
  • As of Q3 2025, Chemours' Change in Accured Expenses stood at $9.0 million, which was down 8636.36% from $88.0 million recorded in Q2 2025.
  • In the past 5 years, Chemours' Change in Accured Expenses registered a high of $602.0 million during Q2 2023, and its lowest value of -$644.0 million during Q2 2024.
  • In the last 5 years, Chemours' Change in Accured Expenses had a median value of $9.0 million in 2025 and averaged $6.5 million.
  • Data for Chemours' Change in Accured Expenses shows a peak YoY increase of 28409.09% (in 2021) and a maximum YoY decrease of 33402.78% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Chemours' Change in Accured Expenses stood at -$337.0 million in 2021, then rose by 5.34% to -$319.0 million in 2022, then soared by 94.36% to -$18.0 million in 2023, then crashed by 100.0% to -$36.0 million in 2024, then soared by 125.0% to $9.0 million in 2025.
  • Its Change in Accured Expenses was $9.0 million in Q3 2025, compared to $88.0 million in Q2 2025 and -$5.0 million in Q1 2025.